9 Thomas, M.K., et al., Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
Bhrer C, Endesfelder S, Scheuer T, Schmitz T
Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway
This process succeeds in approximately 70% of cases with proper medical justification
K23 DK116720-01), in addition to research support by Juvenile Diabetes Research Foundation (JDRF), NIDDK/DiaComp, NIDDK/KPMP, Thrasher Research Fund, International Society of Pediatric and Adolescent Diabetes (ISPAD), Colorado Clinical & Translational Sciences Institute (CCTSI) and Center for Womens Health Research at University of Colorado